Correction: athenex to provide corporate and financial update for the fourth quarter and full year 2021, on march 16, 2022

Buffalo, n.y., march 14, 2022 (globe newswire) -- athenex (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the company will provide a corporate and financial update for the fourth quarter and full year 2021, on wednesday, march 16, 2022. athenex's management team will host a conference call and live audio webcast at 4:30 p.m. eastern time. please note the call is being rescheduled from the previously announced date of march 15 at 8:00 a.m. eastern time.
ATNX Ratings Summary
ATNX Quant Ranking